388 related articles for article (PubMed ID: 22921312)
1. Development of a next-generation sequencing method for BRCA mutation screening: a comparison between a high-throughput and a benchtop platform.
Chan M; Ji SM; Yeo ZX; Gan L; Yap E; Yap YS; Ng R; Tan PH; Ho GH; Ang P; Lee AS
J Mol Diagn; 2012 Nov; 14(6):602-12. PubMed ID: 22921312
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Ion Torrent PGM sequencing workflow for the routine rapid detection of BRCA1 and BRCA2 germline mutations.
Zanella I; Merola F; Biasiotto G; Archetti S; Spinelli E; Di Lorenzo D
Exp Mol Pathol; 2017 Apr; 102(2):314-320. PubMed ID: 28263838
[TBL] [Abstract][Full Text] [Related]
3. Detection of genomic variations in BRCA1 and BRCA2 genes by long-range PCR and next-generation sequencing.
Hernan I; Borràs E; de Sousa Dias M; Gamundi MJ; Mañé B; Llort G; Agúndez JA; Blanca M; Carballo M
J Mol Diagn; 2012; 14(3):286-93. PubMed ID: 22426013
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of a Next-Generation Sequencing Assay for BRCA1 and BRCA2 Variants for the Clinical Laboratory.
Strom CM; Rivera S; Elzinga C; Angeloni T; Rosenthal SH; Goos-Root D; Siaw M; Platt J; Braastadt C; Cheng L; Ross D; Sun W
PLoS One; 2015; 10(8):e0136419. PubMed ID: 26295337
[TBL] [Abstract][Full Text] [Related]
5. Detection of false positive mutations in BRCA gene by next generation sequencing.
Suryavanshi M; Kumar D; Panigrahi MK; Chowdhary M; Mehta A
Fam Cancer; 2017 Jul; 16(3):311-317. PubMed ID: 27848044
[TBL] [Abstract][Full Text] [Related]
6. Long-range PCR and next-generation sequencing of BRCA1 and BRCA2 in breast cancer.
Ozcelik H; Shi X; Chang MC; Tram E; Vlasschaert M; Di Nicola N; Kiselova A; Yee D; Goldman A; Dowar M; Sukhu B; Kandel R; Siminovitch K
J Mol Diagn; 2012 Sep; 14(5):467-75. PubMed ID: 22874498
[TBL] [Abstract][Full Text] [Related]
7. The molecular analysis of BRCA1 and BRCA2: Next-generation sequencing supersedes conventional approaches.
D'Argenio V; Esposito MV; Telese A; Precone V; Starnone F; Nunziato M; Cantiello P; Iorio M; Evangelista E; D'Aiuto M; Calabrese A; Frisso G; D'Aiuto G; Salvatore F
Clin Chim Acta; 2015 Jun; 446():221-5. PubMed ID: 25896959
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of the breast cancer genes BRCA1 and BRCA2 using amplicon-based massive parallel pyrosequencing.
Michils G; Hollants S; Dehaspe L; Van Houdt J; Bidet Y; Uhrhammer N; Bignon YJ; Vermeesch JR; Cuppens H; Matthijs G
J Mol Diagn; 2012 Nov; 14(6):623-30. PubMed ID: 23034506
[TBL] [Abstract][Full Text] [Related]
9. Massive parallel amplicon sequencing of the breast cancer genes BRCA1 and BRCA2: opportunities, challenges, and limitations.
De Leeneer K; Hellemans J; De Schrijver J; Baetens M; Poppe B; Van Criekinge W; De Paepe A; Coucke P; Claes K
Hum Mutat; 2011 Mar; 32(3):335-44. PubMed ID: 21305653
[TBL] [Abstract][Full Text] [Related]
10. BRCA-analyzer: Automatic workflow for processing NGS reads of BRCA1 and BRCA2 genes.
Kechin A; Khrapov E; Boyarskikh U; Kel A; Filipenko M
Comput Biol Chem; 2018 Dec; 77():297-306. PubMed ID: 30408727
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Ion Personal Genome Machine Platforms for the Detection of Variants in
Hwang SM; Lee KC; Lee MS; Park KU
Cancer Res Treat; 2018 Jan; 50(1):255-264. PubMed ID: 28392550
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of an amplicon-based next-generation sequencing panel for detection of BRCA1 and BRCA2 genetic variants.
Shin S; Hwang IS; Lee ST; Choi JR
Breast Cancer Res Treat; 2016 Aug; 158(3):433-40. PubMed ID: 27383479
[TBL] [Abstract][Full Text] [Related]
13. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K
BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519
[TBL] [Abstract][Full Text] [Related]
14. Targeted, high-depth, next-generation sequencing of cancer genes in formalin-fixed, paraffin-embedded and fine-needle aspiration tumor specimens.
Hadd AG; Houghton J; Choudhary A; Sah S; Chen L; Marko AC; Sanford T; Buddavarapu K; Krosting J; Garmire L; Wylie D; Shinde R; Beaudenon S; Alexander EK; Mambo E; Adai AT; Latham GJ
J Mol Diagn; 2013 Mar; 15(2):234-47. PubMed ID: 23321017
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous detection of BRCA mutations and large genomic rearrangements in germline DNA and FFPE tumor samples.
Enyedi MZ; Jaksa G; Pintér L; Sükösd F; Gyuris Z; Hajdu A; Határvölgyi E; Priskin K; Haracska L
Oncotarget; 2016 Sep; 7(38):61845-61859. PubMed ID: 27533253
[TBL] [Abstract][Full Text] [Related]
16. Performance evaluation of the next-generation sequencing approach for molecular diagnosis of hereditary hearing loss.
Sivakumaran TA; Husami A; Kissell D; Zhang W; Keddache M; Black AP; Tinkle BT; Greinwald JH; Zhang K
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):1007-16. PubMed ID: 23525850
[TBL] [Abstract][Full Text] [Related]
17. Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients.
Malapelle U; Vigliar E; Sgariglia R; Bellevicine C; Colarossi L; Vitale D; Pallante P; Troncone G
J Clin Pathol; 2015 Jan; 68(1):64-8. PubMed ID: 25378536
[TBL] [Abstract][Full Text] [Related]
18. Next-Generation Sequencing Workflow for NSCLC Critical Samples Using a Targeted Sequencing Approach by Ion Torrent PGM™ Platform.
Vanni I; Coco S; Truini A; Rusmini M; Dal Bello MG; Alama A; Banelli B; Mora M; Rijavec E; Barletta G; Genova C; Biello F; Maggioni C; Grossi F
Int J Mol Sci; 2015 Dec; 16(12):28765-82. PubMed ID: 26633390
[TBL] [Abstract][Full Text] [Related]
19. Validation and optimization of the Ion Torrent S5 XL sequencer and Oncomine workflow for BRCA1 and BRCA2 genetic testing.
Shin S; Kim Y; Chul Oh S; Yu N; Lee ST; Rak Choi J; Lee KA
Oncotarget; 2017 May; 8(21):34858-34866. PubMed ID: 28422718
[TBL] [Abstract][Full Text] [Related]
20. Enhanced mismatch mutation analysis: simultaneous detection of point mutations and large scale rearrangements by capillary electrophoresis, application to BRCA1 and BRCA2.
Houdayer C; Moncoutier V; Champ J; Weber J; Viovy JL; Stoppa-Lyonnet D
Methods Mol Biol; 2010; 653():147-80. PubMed ID: 20721742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
